Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014)
Abeona Therapeutics (ABEO) posted quarterly Other Non Operating Income of -$11.3 million for Q4 2014, down 37.8% year-over-year from -$18.2 million in Q4 2013, and down 1514.29% quarter-over-quarter from -$700000.0 in Q3 2014.
Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014) Analysis & Trends
Abeona Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$11.3 million for Q4 2014.
- In Q4 2014, Other Non Operating Income fell 37.8% year-over-year to -$11.3 million; the TTM figure through Sep 2015 stood at -$11.3 million (up 43.53% YoY), while the FY2025 annual figure was $141000.0, changed N/A from the prior year.
- Other Non Operating Income for Q4 2014 stood at -$11.3 million, down from -$700000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $33.8 million in Q4 2012, with the low at -$13.9 million in Q3 2012.
- The 4-year median for Other Non Operating Income is $299500.0 (2012), against an average of -$239437.5.
- Peak annual rise in Other Non Operating Income reached 1876.03% in 2012, while the deepest fall reached 1321.44% in 2012.
- Abeona Therapeutics' Other Non Operating Income stood at -$1.9 million in 2011, then surged by 1876.03% to $33.8 million in 2012, then plunged by 124.27% to -$8.2 million in 2013, then tumbled by 37.8% to -$11.3 million in 2014.
- Business Quant data shows ABEO's Other Non Operating Income at -$11.3 million in Q4 2014, -$700000.0 in Q3 2014, and -$11.7 million in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -11.30 Mn |
| Sep 30, 2014 | -700,000.00 |
| Jun 30, 2014 | -11.69 Mn |
| Mar 31, 2014 | 583,000.00 |
| Dec 31, 2013 | -8.20 Mn |
| Sep 30, 2013 | 168,000.00 |
| Jun 30, 2013 | 3.27 Mn |
| Mar 31, 2013 | 4.78 Mn |
| Dec 31, 2012 | 33.78 Mn |
| Sep 30, 2012 | -13.90 Mn |
| Jun 30, 2012 | 431,000.00 |
| Mar 31, 2012 | -2.46 Mn |
| Dec 31, 2011 | -1.90 Mn |
| Sep 30, 2011 | 1.14 Mn |
| Jun 30, 2011 | 939,000.00 |
| Mar 31, 2011 | 1.24 Mn |